Apyx medical corporation appoints matthew hill as chief financial officer

Clearwater, fla.--(business wire)--apyx medical corporation (nasdaq:apyx) (“apyx medical;” the “company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as renuvion®, today announced the appointment of matthew hill to the position of chief financial officer, effective december 4, 2023. mr. hill succeeds tara semb, whose departure was announced by the company on november 9, 2023. “matt joins our executive leadership team with over 30 years of fin.
APYX Ratings Summary
APYX Quant Ranking